Metabolic syndrome and cognitive function: A population-based follow-up study in elderly women

Dementia and Geriatric Cognitive Disorders

Volumn 23, Issue 1, 2006, Pages 29-34

  Komulainen, Pirjo ^a   Lakka, Timo A ^a   Kivipelto, Miia ^a,d   Hassinen, Maija ^a   Helkala, Eeva Liisa ^a   Haapala, Irja ^e   Nissinen, Aulikki ^c   Rauramaa, Rainer ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cognitive function; Elderly women; Metabolic syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COGNITION; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MEMORY DISORDER; METABOLIC SYNDROME X; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; POPULATION RESEARCH; POPULATION RISK; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SENESCENCE;

AGED; BODY MASS INDEX; CHOLESTEROL; COGNITION DISORDERS; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; METABOLIC SYNDROME X; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POPULATION SURVEILLANCE;

EID: 33845731730     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096636     Document Type: Article

References (30)

1. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B, on behalf of the participants of the International Psychogeriatric Association Expert Conference on mild cognitive impairment: Mild cognitive impairment. Lancet 2006;367:1262-1270.
2. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
3. Fishel MA, Watson GS, Montine TJ, Wang Q, Green PS, Kulstad JJ, Cook DG, Peskind ER, Baker LD, Goldgaber D, Nie W, Asthana S, Plymate SR, Schwartz MW, Craft S: Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. Arch Neurol 2005;62:1539-1544.
4. Craft S, Watson GS: Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004;3:169-178.
5. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM: Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999;53:1937-1942.
6. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322:1447-1451.
7. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A: 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
8. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB: The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292:2237-2242.
9. Kalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petrovitch H, Ross GW, Havlik RJ, Launer LJ: Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 2000;20:2255-2260.
10. Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A: Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol 1994;23:495-504.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
12. Rauramaa R, Vaisanen SB, Rankinen T, Penttila IM, Saarikoski S, Tuomilehto J, Nissinen A: Inverse relation of physical activity and apolipoprotein AI to blood pressure in elderly women. Med Sci Sports Exerc 1995;27:164-169.
13. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
14. Heun R, Burkart M, Wolf C, Benkert O: Effect of presentation rate on word list learning in patients with dementia of the Alzheimer type. Dement Geriatr Cogn Disord 1998;9:214-218.
15. Nyberg L, Nilsson LG, Olofsson U, Backman L: Effects of division of attention during encoding and retrieval on age differences in episodic memory. Exp Aging Res 1997;23:137-143.
16. Einstein GO, Smith RE, McDaniel MA, Shaw P: Aging and prospective memory: the influence of increased task demands at encoding and retrieval. Psychol Aging 1997;12:479-488.
17. Stroop JR: Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643.
18. Wechsler D: Wechsler Adult Intelligence Scale Manual. New York, Psychological Corporation, 1944.
19. Zung WW: A self-rating depression scale. Arch Gen Psychiatry 1965;12:63-70.
20. Zhang J, McKeown RE, Hajjar I: Serum cholesterol levels are associated with impaired recall memory among older people. Age Ageing 2005;34:178-182.
21. Wolf H, Hensel A, Arendt T, Kivipelto M, Winblad B, Gertz HJ: Serum lipids and hippocampal volume: the link to Alzheimer's disease? Ann Neurol 2004;56:745-748.
22. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfieger FW: CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001;294:1354-1357.
23. Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ: High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:1987-1994.
24. Olesen OF, Dago L: High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils. Biochem Biophys Res Commun 2000;270:62-66.
25. Bonora E: The metabolic syndrome and cardiovascular disease. Ann Med 2006;38:64-80.
26. Dantoine TF, Drouet M, Debord J, Merle L, Cogne M, Charmes JP: Paraoxonase 1 192/55 gene polymorphisms in Alzheimer's disease. Ann NY Acad Sci 2002;977:239-244.
27. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, Cummings SR: Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 2000;160:174-180.
28. Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, Kervinen K, Kesaniemi A, Riekkinen PJ, Laakso M: Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross-sectional population-based study. BMJ 1997;315:1045-1049.
29. Logroscino G, Kang JH, Grodstein F: Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ 2004;328:548.
30. Launer LJ, Wind AW, Deeg DJ: Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly. Am J Epidemiol 1994;139:803-812.